Search

everythinglearnresearchcommunity

for

Search:↓

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Alopecia areata greatly affects people's life quality, mental health, and work life.

More people are using Google to search for skin problems like itch, hair loss, and rashes.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Functionalized hydrogels can help heal tissues and fight infections by delivering beneficial bacteria and antimicrobials.

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

New genetic variants linked to albinism were found in Pakistani families.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Skin acetyl-CoA synthesis is crucial for overall lipid balance.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Berberine delivery systems improve wound healing by enhancing bioavailability, reducing inflammation, and promoting tissue regeneration.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.